Cargando…
研究者发起的临床研究用于支持新药研发面临的挑战
A large number of investigator-initiated clinical trials (IIT) were conducted in China, some of them should play an important supporting role in new drug development. Due to the large number, small scale and uneven quality of IIT in China, especially a big gap between the IIT and industry-sponsored...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346150/ https://www.ncbi.nlm.nih.gov/pubmed/35899450 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.31 |